Insurers prefer generic drugs because they cut costs by 80-85% while maintaining effectiveness. Preferred generic lists guide prescriptions, lower premiums, and save billions - but can create access barriers for complex medications like biosimilars.
Insurers prefer generic drugs because they cut costs by 80-85% while maintaining effectiveness. Preferred generic lists guide prescriptions, lower premiums, and save billions - but can create access barriers for complex medications like biosimilars.
Pharmaceuticals
